1 articles on this topic
Specialized medical device marketing crashes against a fragmented, risk-averse system where clinical value isn't enough. Your breakthrough device needs more than efficacy; it must navigate payer politics and physician inertia, a battle conventional marketing ignores.
We use cookies to improve your experience and analyse site traffic. By clicking Accept, you consent to our use of cookies. Privacy Policy